Carcinoma of Unknown Primary Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP)
Condition: Carcinoma of Unknown Primary Intervention: Drug: Pembrolizumab Injection Sponsor: AHS Cancer Control Alberta Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2018 Category: Research Source Type: clinical trials
